Aidan Seeley
Direktor/Vorstandsmitglied bei British Pharmacological Society
Ursprung des Netzwerks ersten Grades von Aidan Seeley
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
British Pharmacological Society
 British Pharmacological Society Investment Trusts/Mutual FundsMiscellaneous The British Pharmacological Society is a charity and membership organization that aims to promote and advance the field of pharmacology. The private company is based in London, UK. The British company leads the way in researching and applying pharmacology worldwide. The company was founded in 1931. Rachel Lambert-Forsyth has been the CEO of the company since 2020.
22
| Private Company | Investment Trusts/Mutual Funds | 22 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Aidan Seeley
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| University of London | College/University | Doctorate Degree Doctorate Degree Doctorate Degree Undergraduate Degree Doctorate Degree Undergraduate Degree Doctorate Degree | |
| King's College London | College/University | Undergraduate Degree Undergraduate Degree Corporate Officer/Principal Undergraduate Degree | |
| Imperial College London | College/University | Graduate Degree Doctorate Degree Undergraduate Degree | |
Society For Neuroscience
 Society For Neuroscience Miscellaneous Commercial ServicesCommercial Services The Society for Neuroscience is an organization with over 36,000 members in more than 95 countries. The non-profit company is based in Washington. The organization also engages in science advocacy and public policy, including an annual Capitol Hill Day, and has various public outreach efforts, such as the interactive collection of public-facing resources on BrainFacts.org. It was founded in 1969 and offers year-round programming, including the publication of two scientific journals, professional development resources, and career training through Neuronline. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
The Medical Research Council
 The Medical Research Council Miscellaneous Commercial ServicesCommercial Services The Medical Research Council provides human healthcare and social services. It offers funding for biomedical spectrum, fundamental lab-based science, clinical trials and all major disease areas. The company was founded in 1913 and is headquartered in Swindon, the United Kingdom. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| Aventis Pharma UK | Corporate Officer/Principal Corporate Officer/Principal | ||
| GSK PLC | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| Glasgow Caledonian University | College/University | Doctorate Degree | |
| International Society for the Study of Xenobiotics | President | ||
| The University of Sheffield | College/University | Corporate Officer/Principal | |
Certara UK Ltd.
 Certara UK Ltd. BiotechnologyHealth Technology Certara UK Ltd. provides platforms for the modeling and simulation of pharmacokinetics and pharmacodynamics in virtual human populations and virtual laboratory animals. The company was founded by Geoffrey Thomas Tucker, Amin Rostami-Hodjegan, and John Evans on May 15, 2001 and is headquartered in London, the United Kingdom. | Biotechnology | Founder | |
ReproCELL Europe Ltd.
 ReproCELL Europe Ltd. Miscellaneous Commercial ServicesCommercial Services Part of ReproCELL, Inc., ReproCELL Europe Ltd. is a British company that specializes in providing solutions for translating scientific discoveries into therapies. The company is based in Glasgow, UK. The company's expertise lies in human tissue and stem cells, and they offer consultation services to researchers facing challenges in their research. David C. Bunton has been the CEO of the company since 2017. | Miscellaneous Commercial Services | Chief Executive Officer | |
| Safety Pharmacology Society | Corporate Officer/Principal | ||
Neusentis, Inc.
 Neusentis, Inc. Pharmaceuticals: MajorHealth Technology Neusentis is a biopharmaceutical company, which is focused on the discovery, development and commercialization of novel orally-administered small molecule drugs that modulate ion channel targets. The company has developed an integrated technology platform that allows for the efficient discovery of drug leads. The firm is conducting research and development activities in a number of disease areas, including epilepsy, pain and inflammation. Icagen has two clinical stage programs in epilepsy and pain. The company was formerly known as Icagen, Inc. It was founded by Andre L. Lamotte and P. Kay Wagoner on November 23, 1992 and is headquartered in Durham, NC. | Pharmaceuticals: Major | Director/Board Member | |
| University of Glasgow | College/University | Undergraduate Degree | |
Biopta Ltd.
 Biopta Ltd. Miscellaneous Commercial ServicesCommercial Services Biopta Ltd. provides biological research and human tissues in drug development. It conducts research on the effect of drug activity prior to clinical trials using fresh human tissues. The firm engages in the use of functional human tissue to predict drug activity prior to clinical trials. It provides lab services, comparative pharmacology, clinical biopsies, in vitro and ex vivo techniques, and customized services, as well as cardiac, vascular, respiratory, gastrointestinal, human absorption, skin, and genitourinary related services. The company was founded by David Bunton and Chris Hillier and in 2002 and is headquartered in Glasgow, the United Kingdom. | Miscellaneous Commercial Services | Founder | |
| DIUL GROUP | Pharmaceuticals: Major | Director/Board Member | |
RNIB Charity
 RNIB Charity Miscellaneous Commercial ServicesCommercial Services RNIB Charity is a non-profit charitable organization that provides support and advice to people with sight problems. The non-profit company is based in London, UK. The British company was founded in 2014. | Miscellaneous Commercial Services | Director/Board Member | |
Vapogenix, Inc.
 Vapogenix, Inc. Medical/Nursing ServicesHealth Services Vapogenix, Inc. operates as a clinical stage company which develops a new class of non-narcotic analgesics for localized pain. Its products are formulated volatile anesthetics; currently unformulated volatile anesthetics are used only as general anesthetics, by inhalation. The company was founded by Allen W. Burton, Phillip C. Phan and Danguole Spakevicius Altman in November 2007 and is headquartered in Houston, TX. | Medical/Nursing Services | Chief Executive Officer | |
| University of Oxford | College/University | Doctorate Degree | |
| GlaxoWellcome /Pharmocology Unit/ | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Encysive Pharmaceuticals, Inc.
 Encysive Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Encysive Pharmaceuticals, Inc. discovers, develops and markets drugs for the treatment of cardiovascular, vascular and related inflammatory diseases. The firm focuses its research and development programs on the treatment and prevention of interrelated diseases of the vascular endothelium, inflammatory cascade and vascular diseases. The company was founded by James T. Willerson in 1989 and is headquartered in Houston, TX. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Ananda Developments Plc
 Ananda Developments Plc Investment ManagersFinance Ananda Developments Plc engages in the provision of cannabinoid medicines for the treatment of complex, chronic inflammatory pain conditions. The company was founded on January 19, 2018, and is headquartered in London, the United Kingdom. | Investment Managers | Director/Board Member | |
PrEP Biopharm Ltd.
 PrEP Biopharm Ltd. Pharmaceuticals: MajorHealth Technology PrEP Biopharm Ltd. develops and manufactures biopharmaceutical products. The British company was founded in 2015 by Ryan Muldoon and Bruce A. Malcolm. Ryan Muldoon has been the CEO since 2015. | Pharmaceuticals: Major | Director/Board Member | |
International Pharmaceutical Federation
 International Pharmaceutical Federation Miscellaneous Commercial ServicesCommercial Services The International Pharmaceutical Federation (FIP) is an organization that focuses on higher education for health professionals, specifically in the field of pharmaceutical education. The non-profit company is based in The Hague, Netherlands. The Dutch company's FIP UNESCO-UNITWIN program was the first of its kind. | Miscellaneous Commercial Services | Chairman | |
| The British Toxicology Society | Corporate Officer/Principal | ||
The Francis Crick Institute Ltd.
 The Francis Crick Institute Ltd. Medical/Nursing ServicesHealth Services The Francis Crick Institute Ltd. operates as a biomedical discovery institute dedicated to understanding the scientific mechanisms of living things. The firms works helps to understand why disease develops and to find new ways to treat, diagnose, and prevent illnesses such as cancer, heart disease, stroke, infections, and neurodegenerative diseases. The company is headquartered in London, the United Kingdom. | Medical/Nursing Services | Director/Board Member | |
| Società Italiana Di Neuroscienze | President | ||
| American Society for Pharmacology & Experimental Therapeutic | Corporate Officer/Principal | ||
| ARTERRA BIOSCIENCE S.P.A. | Biotechnology | Director/Board Member | |
| VALIRX PLC | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| UCL Medical School | College/University | Doctorate Degree | |
| C4X DISCOVERY HOLDINGS PLC | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| ABSCI CORPORATION | Biotechnology | Director/Board Member | |
| DIZAL (JIANGSU) PHARMACEUTICAL CO., LTD. | Miscellaneous Commercial Services | Director/Board Member | |
| Cambridge Judge Business School | College/University | Director/Board Member | |
| University of Uppsala | College/University | Doctorate Degree | |
Dizal Pharma
 Dizal Pharma BiotechnologyHealth Technology Dizal Pharma is a Chinese biotechnology company that operates in an undisclosed location. The company was founded in 2017, and its CEO is Xiao Lin Zhang. | Biotechnology | Director/Board Member | |
Precision Medicine Catapult
 Precision Medicine Catapult BiotechnologyHealth Technology Precision Medicine Catapult is a British company that engages in the research and development of biotechnology. The private company is based in Oxford, UK. | Biotechnology | Director/Board Member | |
Neuroscience Research Australia
 Neuroscience Research Australia Miscellaneous Commercial ServicesCommercial Services Neuroscience Research Australia operates as a not-for-profit research institute. The firm carries medical research on brain and nervous system. The company is headquartered in Sydney, Australia. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
The Association of the British Pharmaceutical Industry
 The Association of the British Pharmaceutical Industry Miscellaneous Commercial ServicesCommercial Services The Association of the British Pharmaceutical Industry is a non-profit organization, which engages in the research and development of medicines. It focuses on biosciences. The company is headquartered in London, the United Kingdom. | Miscellaneous Commercial Services | Director/Board Member | |
| ASTRAZENECA PLC | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| The University of Nottingham | College/University | Director/Board Member | |
Revolo Biotherapeutics Ltd.
 Revolo Biotherapeutics Ltd. Pharmaceuticals: MajorHealth Technology Revolo Biotherapeutics Ltd. develops immunologic and inflammatory medications. It develops disease resetting therapeutics for immuno-inflammatory diseases. The company was founded in 2011 and is headquartered in Stevenage, the United Kingdom. | Pharmaceuticals: Major | Chairman | |
EpiEndo Pharmaceuticals ehf
 EpiEndo Pharmaceuticals ehf BiotechnologyHealth Technology EpiEndo Pharmaceuticals ehf is a clinical-stage biopharmaceutical company based in Reykjavik, Iceland. The Icelander company focuses on enhancing epithelial barrier integrity to treat inflammatory disorders, with a primary focus on chronic respiratory diseases. The company recently appointed Dr. Kate Hanrott as Director of Clinical Operations and Sciences, bringing extensive experience to the role. EpiEndo Pharmaceuticals will be attending the Bio International Convention in June 2023. EpiEndo Pharmaceuticals was founded in 2014 by Fridrik Gardarsson, and Maria Bech has been the CEO of the company since 2021. | Biotechnology | Chairman |
Statistik
International
| Vereinigtes Königreich | 34 |
| Vereinigte Staaten | 10 |
| Italien | 3 |
| China | 3 |
| Niederlande | 2 |
Sektoral
| Health Technology | 20 |
| Consumer Services | 12 |
| Commercial Services | 12 |
| Health Services | 3 |
| Finance | 2 |
Operativ
| Director/Board Member | 50 |
| Corporate Officer/Principal | 44 |
| Doctorate Degree | 11 |
| President | 11 |
| Founder | 10 |
Am stärksten vernetzte Beziehungen
- Börse
- Insiders
- Aidan Seeley
- Unternehmensverbindungen
